Literature DB >> 20824476

Systemic lupus erythematosus: from genes to organ damage.

Vasileios C Kyttaris1.   

Abstract

Systemic lupus erythematosus (SLE) is a disease characterized by inappropriate response to self-antigens. Genetic, environmental and hormonal factors are believed to contribute to the development of the disease. We think of SLE pathogenesis as occurring in three phases of variable duration. A series of regulatory failures during the ontogeny of the immune system lead to the emergence of auto-reactive clones and the production of auto-antibodies (phase I). As the immune response to self-antigens broadens, the auto-antibody repertoire is enriched (phase II) and clinical manifestations eventually ensue (phase III). The final result is tissue damage that if not treated will lead to the functional failure of such important organs as the kidney and brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824476      PMCID: PMC3153363          DOI: 10.1007/978-1-60761-800-3_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  90 in total

Review 1.  The role of sex hormones in systemic lupus erythematosus.

Authors:  R G Lahita
Journal:  Curr Opin Rheumatol       Date:  1999-09       Impact factor: 5.006

2.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.

Authors:  Akinori Takaoka; Hideyuki Yanai; Seiji Kondo; Gordon Duncan; Hideo Negishi; Tatsuaki Mizutani; Shin-Ichi Kano; Kenya Honda; Yusuke Ohba; Tak W Mak; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-01-23       Impact factor: 49.962

3.  Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.

Authors:  Yuang-Taung Juang; Ying Wang; Elena E Solomou; Yansong Li; Christian Mawrin; Klaus Tenbrock; Vasileios C Kyttaris; George C Tsokos
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 4.  Gender impact in systemic lupus erythematosus.

Authors:  M E Soto; M Vallejo; F Guillén; J A Simón; E Arena; P A Reyes
Journal:  Clin Exp Rheumatol       Date:  2004 Nov-Dec       Impact factor: 4.473

5.  A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells.

Authors:  Kensei Tsuzaka; Yumiko Setoyama; Keiko Yoshimoto; Kiyono Shiraishi; Katsuya Suzuki; Tohru Abe; Tsutomu Takeuchi
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

6.  Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3'-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus.

Authors:  Bhabadeb Chowdhury; Christos G Tsokos; Sandeep Krishnan; James Robertson; Carolyn U Fisher; Rahul G Warke; Vishal G Warke; Madhusoodana P Nambiar; George C Tsokos
Journal:  J Biol Chem       Date:  2005-03-02       Impact factor: 5.157

7.  Defective B cell tolerance checkpoints in systemic lupus erythematosus.

Authors:  Sergey Yurasov; Hedda Wardemann; Johanna Hammersen; Makoto Tsuiji; Eric Meffre; Virginia Pascual; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307

8.  The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.

Authors:  D Bharadwaj; M P Stein; M Volzer; C Mold; T W Du Clos
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

9.  Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.

Authors:  J F Cloutier; A Veillette
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

10.  Complement-dependent clearance of apoptotic cells by human macrophages.

Authors:  D Mevorach; J O Mascarenhas; D Gershov; K B Elkon
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  12 in total

Review 1.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 2.  Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay.

Authors:  Stefano Palmucci; Federica Galioto; Giulia Fazio; Agata Ferlito; Giovanna Cancemi; Alessia Di Mari; Gianluca Sambataro; Domenico Sambataro; Giovanni Zanframundo; Letizia Antonella Mauro; Pietro Valerio Foti; Carlo Vancheri; Antonio Basile
Journal:  Insights Imaging       Date:  2022-06-29

3.  Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice.

Authors:  Xin Wei; Gang Zhao; Xiaobei Wang; Nagsen Gautam; Zhenshan Jia; Zhifeng Zhao; Dexuan Kong; Fan Zhang; Sushil Kumar; Yuanyuan Sun; Ningrong Chen; Xiaoyan Wang; Libin Yang; Rongguo Ren; Geoffrey M Thiele; Tatiana K Bronich; James R O'Dell; Yazen Alnouti; Dong Wang
Journal:  Nanomedicine       Date:  2020-07-15       Impact factor: 5.307

4.  Spleen tyrosine kinase (Syk) regulates systemic lupus erythematosus (SLE) T cell signaling.

Authors:  Alexandros P Grammatikos; Debjani Ghosh; Amy Devlin; Vasileios C Kyttaris; George C Tsokos
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States.

Authors:  Richard A Furie; Daniel J Wallace; Cynthia Aranow; James Fettiplace; Barbara Wilson; Prafull Mistry; David A Roth; David Gordon
Journal:  Arthritis Rheumatol       Date:  2018-04-25       Impact factor: 10.995

6.  Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus.

Authors:  Shu Xu; Hong Yang; Yue Zhuo; Yangsheng Yu; Hongyan Liao; Song Li; Yinshi Yue; Kaihong Su; Zhixin Zhang
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

7.  Coordinated Induction of Antimicrobial Response Factors in Systemic Lupus Erythematosus.

Authors:  Prathapan Ayyappan; Robert Z Harms; Jane H Buckner; Nora E Sarvetnick
Journal:  Front Immunol       Date:  2019-04-04       Impact factor: 7.561

Review 8.  A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus.

Authors:  Nicki Tiffin; Adebowale Adeyemo; Ikechi Okpechi
Journal:  Orphanet J Rare Dis       Date:  2013-01-07       Impact factor: 4.123

9.  CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE.

Authors:  Zhanyun Da; Liuxia Li; Jin Zhu; Zhifeng Gu; Bo You; Ying Shan; Si Shi
Journal:  J Immunol Res       Date:  2016-09-08       Impact factor: 4.818

10.  Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8.

Authors:  Pattarin Tangtanatakul; Boonyakiat Thammasate; Alain Jacquet; Rangsima Reantragoon; Trairak Pisitkun; Yingyos Avihingsanon; Asada Leelahavanichkul; Nattiya Hirankarn
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.